NYSE: MHMcgraw Hill Inc Stock
$13.10-0.47 (-3.46%)
Updated Aug 14, 2026
McGraw Hill shares are trading... find out Why MH Price Moved with a free WallStreetZen account
Why Price MovedMH Price
$13.10
Fair Value Price
N/A
Market Cap
$2.51B
52 Week Low
$8.95
52 Week High
$18.00
P/E
27.29x
P/B
3.18x
P/S
0.86x
PEG
0.41x
Dividend Yield
N/A
Revenue
$2.12B
Earnings
$92.68M
Gross Margin
81.7%
Operating Margin
12.71%
Profit Margin
4.4%
Debt to Equity
5.82
Operating Cash Flow
$428M
Beta
0.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MH's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Education
Industry Rating
B
MH
Ranked#1 of 25
Ranked#1 of 25
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $1,191.20 | B | |
| $132.01 | B | |
| $82.33 | B |
Be the first to know about important MH news, forecast changes, insider trades & much more!
MH News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MH ($13.10) is trading above its intrinsic value of $12.69, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MH is poor value based on its earnings relative to its share price (27.29x), compared to the US market average (16.24x)
P/E vs Market Valuation
MH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MH due diligence checks available for Premium users.
Valuation
MH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
27.29x
Industry
13.65x
Market
16.24x
MH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.18x
Industry
2.09x
MH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MH price to earnings growth (PEG)
For valuing profitable companies with growth potential
MH is good value based... subscribe to Premium to read more.
PEG Value Valuation
MH's financial health
Profit margin
Revenue
$549.9M
Net Income
$57.9M
Profit Margin
10.5%
MH's Earnings (EBIT) of $269.07M... subscribe to Premium to read more.
Interest Coverage Financials
MH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.4B
Liabilities
$4.6B
Debt to equity
5.82
MH's short-term liabilities ($1.15B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MH's long-term liabilities ($3.45B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$601.0k
Investing
-$58.3M
Financing
-$3.2M
MH's operating cash flow ($428.43M)... subscribe to Premium to read more.
Debt Coverage Financials
MH vs Education Stocks
Mcgraw Hill Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.